NASDAQ:INNV

InnovAge (INNV) Stock Price, News & Analysis

InnovAge logo
$8.91 0.00 (0.00%)
Closing price 04:00 PM Eastern
Extended Trading
$8.91 0.00 (0.00%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About InnovAge Stock (NASDAQ:INNV)

Advanced

Key Stats

Today's Range
$8.24
▼
$9.30
50-Day Range
$8.80
▼
$10.92
52-Week Range
$4.70
▼
$12.64
Volume
747,566 shs
Average Volume
516,261 shs
Market Capitalization
$1.22 billion
P/E Ratio
148.50
Dividend Yield
N/A
Price Target
$10.50
Consensus Rating
Moderate Buy

Company Overview

InnovAge, Inc. provides integrated healthcare and social services to older adults through the Program of All-Inclusive Care for the Elderly (PACE). The program serves people who qualify for nursing-home-level care but can continue living in their communities with coordinated support.

InnovAge’s services include primary and specialty care coordination, nursing, rehabilitation, social services, prescription medications, transportation, in-home assistance and adult day health services. Care is coordinated by interdisciplinary teams and delivered through a combination of community-based centers and support at home.

The company operates PACE programs in Colorado, California, New Mexico, Pennsylvania and Virginia. Its model is designed to bring medical and supportive services together around each participant’s needs, helping eligible older adults remain in their homes and communities.

AI Generated. May Contain Errors.

InnovAge Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
68th Percentile Overall Score

INNV MarketRank™: 
3.37965498357 of 5 stars

InnovAge scored higher than 68% of companies evaluated by MarketBeat, and ranked 217th out of 845 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    InnovAge has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 strong buy rating, 1 buy rating, 1 hold rating, and 1 sell rating.

  • Upside Potential

    InnovAge has a consensus price target of $10.50, representing about 17.8% upside from its current price of $8.91.

  • Amount of Analyst Coverage

    InnovAge has only been the subject of 3 research reports in the past 90 days.

  • Read more about InnovAge's stock forecast and price target.
  • Earnings Growth

    Earnings for InnovAge are expected to grow by 11.36% in the coming year, from $0.44 to $0.49 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of InnovAge is 148.50, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.64.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of InnovAge is 148.50, which means that it is trading at a more expensive P/E ratio than the Healthcare sector average P/E ratio of about 32.77.

  • Price to Book Value per Share Ratio

    InnovAge has a P/B Ratio of 4.71. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about InnovAge's valuation and earnings.
  • Percentage of Shares Shorted

    0.66% of the float of InnovAge has been sold short.
  • Short Interest Ratio / Days to Cover

    InnovAge has a short interest ratio ("days to cover") of 1.44, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in InnovAge has recently decreased by 22.08%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    InnovAge does not currently pay a dividend.

  • Dividend Growth

    InnovAge does not have a long track record of dividend growth.

  • News Sentiment

    InnovAge has a news sentiment score of 0.54. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.39 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 11 news articles for InnovAge this week, compared to 3 articles on an average week.
  • MarketBeat Follows

    Only 1 people have added InnovAge to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, InnovAge insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $120,489,535.00 in company stock.

  • Percentage Held by Insiders

    1.10% of the stock of InnovAge is held by insiders.

  • Percentage Held by Institutions

    12.26% of the stock of InnovAge is held by institutions.

  • Read more about InnovAge's insider trading history.
Receive INNV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InnovAge and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

INNV Stock News Headlines

InnovAge Resolves Federal, State Claims Over Historical Practices
The next convergence is here
In 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This past May, flooding cut the supply route into the largest uranium complex on the planet, and in July Cigar Lake went down a second time. Gerardo Del Real calls this the Third Convergence Event and has backed three small companies positioned in front of it.tc pixel
See More Headlines

INNV Stock Analysis - Frequently Asked Questions

InnovAge's stock was trading at $5.19 at the start of the year. Since then, INNV stock has increased by 71.7% and is now trading at $8.91.

InnovAge Holding Corp. (NASDAQ:INNV) announced its earnings results on Tuesday, November, 3rd. The company reported $0.14 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.09 by $0.05. The business had revenue of $264.76 million for the quarter, compared to analyst estimates of $257.23 million. InnovAge had a net margin of 0.88% and a trailing twelve-month return on equity of 3.63%.
Read the conference call transcript
.

InnovAge (INNV) raised $342 million in an IPO on Thursday, March 4th 2021. The company issued 16,666,667 shares at a price of $20.00-$21.00 per share. J.P. Morgan, Barclays, Goldman Sachs and Citigroup served as the underwriters for the IPO and Baird, William Blair, Piper Sandler, Capital One Securities, Loop Capital Markets, Siebert Williams Shank and Roberts & Ryan were co-managers.

InnovAge's top institutional shareholders include Ghisallo Capital Management LLC (0.50%), Goldman Sachs Group Inc. (0.49%), State Street Corp (0.34%) and Marshall Wace LLP (0.30%). Insiders that own company stock include Carson Anderson & Stow Welsh, Aggregator Lp Ignite, Nicole Damato, Michael Anthony Scarbrough, Richard C Zoretic and Richard C Zoretic.
View institutional ownership trends
.

Shares of INNV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that InnovAge investors own include Walt Disney (DIS), NVIDIA (NVDA), Visa (V), Energy Transfer (ET), American International Group (AIG), Blackstone (BX) and Enterprise Products Partners (EPD).

Company Calendar

Last Earnings
11/03/2026
Today
11/19/2026
Next Earnings (Estimated)
2/02/2027
Fiscal Year End
6/30/2027

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Providers & Services
Sub-Industry
Healthcare Services
Current Symbol
NASDAQ:INNV
Previous Symbol
OTCMKTS:INNV
CIK
1834376
Fax
N/A
Employees
2,500
Year Founded
1990

Price Target and Rating

High Price Target
$14.00
Low Price Target
$7.00
Potential Upside/Downside
+17.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.06
Trailing P/E Ratio
148.50
Forward P/E Ratio
18.18
P/E Growth
N/A
Net Income
-$2.54 million
Net Margins
0.88%
Pretax Margin
1.22%
Return on Equity
3.63%
Return on Assets
1.64%

Debt

Debt-to-Equity Ratio
0.20
Current Ratio
1.16
Quick Ratio
1.16

Sales & Book Value

Annual Sales
$989.71 million
Price / Sales
1.23
Cash Flow
$0.14 per share
Price / Cash Flow
62.42
Book Value
$1.89 per share
Price / Book
4.71

Miscellaneous

Outstanding Shares
136,460,000
Free Float
134,956,000
Market Cap
$1.22 billion
Optionable
Optionable
Beta
0.16

Social Links

The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report

This page (NASDAQ:INNV) was last updated on 11/19/2026 by MarketBeat.com Staff.
From Our Partners